PFIZER INC Income (Loss) from Equity Method Investments
PFIZER INC (PFE) reported Income (Loss) from Equity Method Investments of $45.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-22.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2018-02-22
- PFIZER INC income (loss) from equity method investments for fiscal 2015 was $45.00M, a 47.67% decline from fiscal 2014.
- PFIZER INC income (loss) from equity method investments for fiscal 2014 was $86.00M.
| Period end | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|
| 2015-12-31 | $45.00M 10-K · filed 2018-02-22 | -$45.00M 10-K · filed 2016-02-29 |
| 2014-12-31 | $86.00M 10-K · filed 2017-02-23 | -$86.00M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |